Tracking a blood marker to predict recovery after brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tracks a hormone called IGF-1 in your blood after a brain bleed to see if its levels can help predict recovery. By joining, you may help doctors better understand and guide treatment for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are aged 18 to 75.
- You have had a bleed in the brain (intracerebral hemorrhage) within the last 3 days.
- Your bleeding is moderate to severe, as measured by a stroke scale (NIHSS score of 5 or more).
- You did not have a previous stroke or brain injury that left you with lasting disability.
- Your body mass index (BMI) is 28 or lower.
- You do not have severe heart, liver, kidney, or lung disease, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in your blood and brain scans that may help doctors better understand and predict outcomes after a spontaneous brain bleed. It is for people with high blood pressure who have had a bleed within the last three days.
This study is looking for a simple blood test that might help predict how well people recover after a brain bleed (intracerebral hemorrhage). If you've recently had this type of bleeding, researchers want to see if certain markers in your blood can give clues about your outlook.
This study is testing a way to predict how well people will recover after a brain bleed (intracerebral hemorrhage). It uses information from the first 24 hours to help doctors and families understand the chances of getting better.
This study looks at people who come to the emergency room with a bleeding stroke (called intracerebral hemorrhage). It aims to learn more about the condition by studying blood tests and brain scans, to find ways to improve outcomes.
This study looks at two proteins in the blood that may be linked to brain swelling after a bleeding stroke (intracerebral hemorrhage). It aims to understand how the body's immune response affects recovery, which could lead to better treatments.
This study looks at brain swelling (“cerebral edema”) after a spontaneous brain bleed and how it relates to outcomes. It mainly involves people who can have early care and MRI scans, to better understand what affects recovery.
Hear when a new Insulin-Like Growth Factor I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.